WebMD

FDA Approves Rhapsido for People With Hives Triggered by Skin Rubbing

The FDA has approved Rhapsido (remibrutinib) for adults with symptomatic dermographism who remain symptomatic despite use of ...
WebMD

FDA Approves Jaypirca for First-Time Treatment of Certain Blood Cancers

The FDA has approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a 17p deletion.